Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective, less costly, or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

Contact
The Investor Relations Group:
Erika Moran, Investor Relations
Janet Vasquez, Public Relations
(212) 825-3210

FINANCIAL TABLES FOLLOWGEOVAX LABS, INC.Condensed Consolidated Statements of Operations Information(amounts in thousands, except per share data)Three Months EndedMarch 31, 2012

2011RevenuesGrant Revenue$
854

$
893Operating expenses:Research and development1,072

838General and administrative513

6621,585

1,500Other income:Interest income1

11

1Net loss$
(730)

$
(606)Loss per common share$  (0.04)

$
(0.04) GEOVAX LABS, INC.Condensed Balance Sheet Information(amounts in thousands)March 31,

Dec. 31,2012

2011Assets:Cash and cash equivalents$
2,240

$
,168Other current assets393

250Total current assets2,633

1,418Property, net 158

176Other assets46

51Total assets$
2,837

$
,645Liabilities and stockholders' equityCurrent liabilities$
510

$
941Stockholders' equity2,327

704Total liabilities and stockho
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 WuXi PharmaTech ... R&D capability and technology platform company serving the pharmaceutical, ... China and the United ... financial results for the second-quarter of 2015 after the ... 2015 (which will be Friday morning, August 14, 2015 ...
(Date:7/29/2015)... 2015  Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" ... of Directors, after careful consideration and with the ... has unanimously rejected the purported revised, highly conditional, ... (NASDAQ: HZNP ) ("Horizon") to acquire all ... all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... REDMOND, Washington , 29 luglio 2015 /PRNewswire/ ... tedesco ha scoperto che l,ingestione quotidiana del probiotico ... microbiota intestinale umano e modifica la produzione intestinale ... insulina. Lo studio riguardava la somministrazione quotidiana di ceppo ... ATCC SD-5865) in compresse utilizzando il sistema di ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
... As part of its ongoing work in the prevention ... Diagnostics is pleased to announce its sponsorship of the ... a kick-off event at Loyola University in Chicago on ... the goal of World MRSA Day is to highlight ...
... 28 Chimerix, Inc., a pharmaceutical company developing orally-available ... and Chief Executive Officer, will present a corporate overview ... 5th, 2010 at 2:00pm PT.  The conference is being ... Mr. Moch will discuss the company,s antiviral ...
Cached Medicine Technology:Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day 2Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day 3Chimerix to Present at 9th Annual BIO Investor Forum 2
(Date:7/29/2015)... ... July 30, 2015 , ... ... their clients, BOC approved provider of online continuing education courses for Athletic ... to their exclusive Andrews Research and Education Sports Medicine Series. , The new ...
(Date:7/29/2015)... ... ... According to data released today by the Centers for Medicare & Medicaid Services, ... $32.50, a figure far lower than was originally projected, the Pharmaceutical Care Management Association ... in American health care. By offering an abundance of competing choices in each region ...
(Date:7/29/2015)... ... ... article published July 23 by the Daily Mail, a new online tool developed ... do in terms of physical activity and caloric intake to lose weight. Based on a ... of calories a person needs to consume to maintain or lose weight at a rate ...
(Date:7/29/2015)... ... ... Sports fans young and old at the National Cherry Festival in Traverse ... joined by A Forever Recovery, a holistic treatment center for substance abuse located in ... Offensive Lineman Lomas Brown, and Tight End Rob Rubick signed foam footballs, provided by ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Pharmacy Collaborative for retail healthcare providers begins in Kissimmee, Fla. The two-day ... and physician assistants can work together to expand access to affordable, high quality ...
Breaking Medicine News(10 mins):Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 2Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 3Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 4
... returned to Iraq's holy city of Najaf on Friday after ... head of one of the most powerful parties in the ... included medical tests in the United States and treatment in ... and will be there for a long time, after he ...
... now breathe a sigh of relief for researchers at ... developed two robotic devices that mimic the human ankle, ... ,Dr. Hugh Herr, Assistant Professor and Director of the ... Discovery News as saying that these spring-enabled, motor-driven devices ...
... identified a tiny bit of genetic code, which helps the ... ,The genetic code is called miR-34a, a microRNA ... are likely to become malignant because of damaged genes in ... acid (RNA), which stick to messenger RNAs, and prevent proteins ...
... death campaigners on Friday expressed concerns that the number of ... in Australia. ,The number of children dying from ... to 87 in 2005, SIDS and Kids Western Australia spokeswoman ... safe sleeping practices for babies had reduced cot deaths from ...
... has issued a warning in all districts after reports from ... eradicated from the world 30 years ago, along the Bangladesh-Myanmar ... Sanchita Bakshi said border security agencies have been asked to ... the symptoms of the disease. ,Local reports said ...
... TV reality show highlighting the need for more organ donors, ... a swirl of controversy, a Dutch channel Friday was to ... her kidney. ,The controversy stirred by "The Big ... but public broadcaster BNN is determined to go ahead. ...
Cached Medicine News:Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2Health News:Genetic Code That Helps Kill Colon Cancer Cells Identified 2Health News:Small Pox Scare Put West Bengal on High Alert 2Health News:Shock TV Reality Organ Donor Show Goes on Air 2Health News:Shock TV Reality Organ Donor Show Goes on Air 3
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Medicine Products: